Unichem Pharmaceuticals USA Inc. recalls
4 recalls filed under Unichem Pharmaceuticals USA Inc.. The most recent was published May 13, 2026.
-
Class III · 6 months ago
Unichem Pharmaceuticals USA Inc. busPIRone Hydrochloride Tablets, USP recall: Subpotent drug
Subpotent drug
-
Class III · 8 months ago
Unichem Pharmaceuticals USA Inc. Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle recall: Tablets/Capsules Imprinted with Wrong ID
Tablets/Capsules Imprinted with Wrong ID
-
Class II · 9 months ago
Unichem Pharmaceuticals USA Inc. Bisoprolol Fumarate and Hydrochlorothiazide tablets recall: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
-
Class I · 1+ years ago
Unichem Pharmaceuticals USA Inc. Cyclobenzaprine Hydrochloride Tablets, USP recall: Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets…
About this page
Unichem Pharmaceuticals USA Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.